NCT00798395

Brief Summary

This trial is to investigate the effect on next-day driving performance and psychomotor performance in healthy volunteers.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Oct 2007

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 25, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 26, 2008

Completed
Last Updated

October 14, 2015

Status Verified

October 1, 2015

Enrollment Period

11 months

First QC Date

November 25, 2008

Last Update Submit

October 12, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Standard Deviation of Lateral Position

    Day 8

Secondary Outcomes (1)

  • Psychomotor and cognitive performance tasks

    Day 8

Study Arms (4)

Treatment 1

EXPERIMENTAL
Drug: Org 50081

Treatment 2

EXPERIMENTAL
Drug: Org 50081

Treatment 3

PLACEBO COMPARATOR
Drug: Placebo

Treatment 4

ACTIVE COMPARATOR
Drug: zopiclone

Interventions

1.5 mg on day 1-7

Treatment 1

Once daily on Day 1-7

Treatment 3

Single dose of 7.5 mg

Treatment 4

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Subject has at least 3 years of car driving experience
  • Subject signs the trial Informed Consent Form
  • Subject is in a healthy condition as judged by the investigator
  • Subject has a regular sleep pattern

You may not qualify if:

  • Subject has insomnia or any other sleep disorder
  • Medication or drug use of any kind prior to the study
  • Relevant history or presence of a significant medical illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersMental Disorders

Interventions

Mirtazapinezopiclone

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

DibenzazepinesHeterocyclic Compounds, 3-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2008

First Posted

November 26, 2008

Study Start

October 1, 2007

Primary Completion

September 1, 2008

Study Completion

September 1, 2008

Last Updated

October 14, 2015

Record last verified: 2015-10